Pediatric Oncology

Top Story

Will CAR T cells become first-line therapy for hematologic malignancies?

Will CAR T cells become first-line therapy for hematologic malignancies?
HemOnc Today, March 25, 2019
Cover Story

New indications may accelerate ‘explosion’ in CAR T-cell therapy, but more education still needed

HemOnc Today, March 25, 2019
Years of research into chimeric antigen receptor T-cell therapy for cancer treatment is finally paying dividends. When Renier J. Brentjens, MD, PhD, director of…
In the Journals

Survival rates after HSCT have not improved among infants with malignant diseases

March 18, 2019
Infants with malignant diseases who underwent allogeneic hematopoietic stem cell transplantation did not demonstrate improved survival rates over a 15-year period…
Point/Counter

Should pediatric cancer survivors previously exposed to neck irradiation undergo ultrasound screening for thyroid cancer?

HemOnc Today, March 10, 2019
POINT We have very limited data on whether active surveillance of patients treated with radiation therapy for a nonthyroid head and neck cancer is associated with benefit…
More Headlines »
CME

Sickle Cell Disease Forum: Innovation in Drug Development and Emerging Science

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »
Video
Meeting News

VIDEO: Late health problems becoming less common in childhood cancer survivors

June 4, 2017
More »